Jane Street Group, LLC Repligen Corp Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $13.4 Million - $18.8 Million	112,200 New	112,200 $16.7 Million
Q1 2022 May 17, 2022	BUY	$161.19 - $257.96 $1.98 Million - $3.17 Million	12,300 Added 45.22%	39,500 $7.43 Million
Q4 2021 Feb 15, 2022	SELL	$247.59 - $304.47 $2.23 Million - $2.74 Million	-9,000 Reduced 24.86%	27,200 $7.2 Million
Q3 2021 Nov 16, 2021	BUY	$194.77 - $324.21 $4.25 Million - $7.07 Million	21,800 Added 151.39%	36,200 $10.5 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $2.02 Million - $2.7 Million	-12,200 Reduced 45.86%	14,400 $2.88 Million
Q1 2021 May 18, 2021	BUY	$180.37 - $226.26 $54,111 - $67,878	300 Added 1.14%	26,600 $5.17 Million
Q4 2020 Feb 17, 2021	BUY	$148.08 - $206.57 $2.7 Million - $3.76 Million	18,200 Added 224.69%	26,300 $5.04 Million
Q3 2020 Nov 17, 2020	BUY	$122.51 - $158.27 $355,279 - $458,983	2,900 Added 55.77%	8,100 $1.2 Million
Q2 2020 Aug 17, 2020	BUY	$94.33 - $140.48 $490,516 - $730,496	5,200 New	5,200 $643,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.